Short answer
Travere Therapeutics, Inc. (TVTX) filed an 8-K current report with the SEC on May 21, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). All 10 director nominees elected to serve through the 2027 annual meeting.
Travere Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- All 10 director nominees elected to serve through the 2027 annual meeting
- Stockholders approved 3,000,000 additional shares under the 2018 Equity Incentive Plan, increasing potential equity dilution
- Executive compensation approved by 73,711,670 votes, signaling continued shareholder support
- Annual say-on-pay vote preferred by 75,003,558 votes, establishing a one-year advisory voting cycle
- Ernst & Young LLP ratified as independent auditor for fiscal 2026 with 80,708,265 votes in favor
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Travere Therapeutics, Inc. 8-K filings
Get the next TVTX 8-K as it lands
Follow TVTX for push alerts, or ask the research agent what this filing means.